Results 241 to 250 of about 1,850,325 (290)

Efficacy of Inebilizumab in N‐MOmentum Trial Participants With or Without Prior Immunosuppressants

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT This post hoc analysis examined the impact of prior immunosuppressants on the long‐term efficacy and safety of inebilizumab, a cluster of differentiation 19+ B‐cell–depleting monoclonal antibody, in participants with aquaporin‐4–seropositive neuromyelitis optica spectrum disorder from the N‐MOmentum trial (NTC02200770).
Bruce A. C. Cree, Beatrice Suero, Sarah Walsh, Romain Marignier, John W. Lindsey, Ho Jin Kim, Dewei She, Daniel Cimbora, Dustin Cavida, Friedemann Paul   +9 more
wiley   +1 more source

Peripheral Neutrophil Activation and Extracellular Trap Formation in Amyotrophic Lateral Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
Markers of neutrophil activation are increased in plasma during ALS, and markers of NET formation associate with ALS survival. ABSTRACT Objectives Peripheral neutrophil levels in amyotrophic lateral sclerosis (ALS) inversely correlate with survival, suggesting a role for neutrophils in disease progression.
Lillia A. Baird, Haley McQuown, Jihyun Park, Samuel J. Teener, Ian F. Webber‐Davis, Andrew D. Carter, Dae‐Gyu Jang, Eva L. Feldman, Stephen A. Goutman, Benjamin J. Murdock   +9 more
wiley   +1 more source

Effect of internet-delivered exposure therapy versus healthy lifestyle promotion for patients with persistent physical symptoms (SOMEX1): a randomized controlled trial with planned moderator analysis. [PDF]

Psychol Med
Hybelius J, Af Winklerfelt Hammarberg S, Salomonsson S, Wachtler C, Epstein M, Olsson A, Strand E, Söderström Winter L, Åkerlund T, Björkander D, Kosic A, Chahin G, Wallert J, Toth-Pal E, Nordin S, Axelsson E.   +15 more
europepmc   +1 more source

The efficacy of conventional and technology assisted cue exposure therapy for treating substance use disorders: a qualitative systematic review. [PDF]

Front Psychiatry
Thaysen-Petersen D, Hammerum SK, Düring SW, Larsen PV, Fink-Jensen A, Mellentin AI.   +5 more
europepmc   +1 more source

Examining why therapists add sessions to the written exposure therapy protocol and whether it improves treatment outcome: A mixed-methods analysis. [PDF]

Psychol Serv
Sloan DM, DeJesus C, Marx BP, Acierno R, Messina M, Thompson-Hollands J.   +5 more
europepmc   +1 more source

Written Exposure Therapy for PTSD Integrated with Cognitive Behavioral Coping Skills for Cannabis Use Disorder After Recent Sexual Assault: A Case Series. [PDF]

Behav Sci (Basel)
Hahn CK, Salim SR, Tilstra-Ferrell EL, Brady KT, Marx BP, Rothbaum BO, Saladin ME, Guille C, Gilmore AK, Back SE.   +9 more
europepmc   +1 more source

Corrigendum to "Reward processes in extinction learning and applications to exposure therapy" [Journal of Anxiety Disorders 106 (2024) 102911]. [PDF]

J Anxiety Disord
Rosenberg BM, Barnes-Horowitz NM, Zbozinek TD, Craske MG.   +3 more
europepmc   +1 more source

Blended Mobile-Based Interventions With Integrated Virtual Reality Exposure Therapy for Anxiety Disorders: Thematic Analysis of Patient Perspectives.

JMIR Hum Factors
Planert J, Hildebrand AS, Machulska A, Roesmann K, Neubert M, Pilgramm S, Pilgramm J, Klucken T.   +7 more
europepmc   +1 more source

Virtual Reality Exposure Therapy for Reducing School Anxiety in Adolescents: Pilot Study.

JMIR Ment Health
Beele G, Liesong P, Bojanowski S, Hildebrand K, Weingart M, Asbrand J, Correll CU, Morina N, Uhlhaas PJ.   +8 more
europepmc   +1 more source